Acurx Pharmaceuticals, Inc.ACXPNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q3 2025 | -25.34% |
| Q2 2025 | 29.88% |
| Q1 2025 | 219.36% |
| Q4 2024 | -77.82% |
| Q3 2024 | -24.83% |
| Q2 2024 | -44.13% |
| Q1 2024 | 11.83% |
| Q4 2023 | 14.58% |
| Q3 2023 | -40.69% |
| Q2 2023 | 11.78% |
| Q1 2023 | -27.60% |
| Q4 2022 | -28.03% |
| Q3 2022 | 2.31% |
| Q2 2022 | -18.05% |
| Q1 2022 | -13.94% |
| Q4 2021 | -14.00% |
| Q3 2021 | -36.64% |
| Q2 2021 | 760.04% |
| Q1 2021 | -8.53% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |